Annual EBITDA
-$29.39 M
-$14.05 M-91.60%
31 December 2023
Summary:
Zomedica annual earnings before interest, taxes, depreciation & amortization is currently -$29.39 million, with the most recent change of -$14.05 million (-91.60%) on 31 December 2023. During the last 3 years, it has fallen by -$13.01 million (-79.40%). ZOM annual EBITDA is now -69208.96% below its all-time high of -$42.40 thousand, reached on 01 February 2015.ZOM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$4.70 M
+$17.40 M+78.75%
30 September 2024
Summary:
Zomedica quarterly earnings before interest, taxes, depreciation & amortization is currently -$4.70 million, with the most recent change of +$17.40 million (+78.75%) on 30 September 2024. Over the past year, it has dropped by -$3.94 million (-525.30%). ZOM quarterly EBITDA is now -195566.67% below its all-time high of -$2400.00, reached on 28 February 2014.ZOM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$54.27 M
-$3.94 M-7.84%
30 September 2024
Summary:
Zomedica TTM earnings before interest, taxes, depreciation & amortization is currently -$54.27 million, with the most recent change of -$3.94 million (-7.84%) on 30 September 2024. Over the past year, it has dropped by -$42.33 million (-354.67%). ZOM TTM EBITDA is now -374141.38% below its all-time high of -$14.50 thousand, reached on 31 May 2013.ZOM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZOM EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -91.6% | -525.3% | -354.7% |
| 3 y3 years | -79.4% | +25.5% | -180.4% |
| 5 y5 years | -78.7% | -77.3% | -119.8% |
ZOM EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -91.6% | at low | -525.3% | +78.8% | -354.7% | at low |
| 5 y | 5 years | -91.6% | at low | -525.3% | +78.8% | -454.7% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +78.8% | <-9999.0% | at low |
Zomedica EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.70 M(-78.7%) | -$54.27 M(+7.8%) |
| June 2024 | - | -$22.10 M(+198.8%) | -$50.32 M(+57.2%) |
| Mar 2024 | - | -$7.39 M(-63.2%) | -$32.02 M(+9.0%) |
| Dec 2023 | -$29.39 M(+91.6%) | -$20.08 M(+2573.4%) | -$29.39 M(+146.2%) |
| Sept 2023 | - | -$751.00 K(-80.2%) | -$11.94 M(-23.9%) |
| June 2023 | - | -$3.79 M(-20.3%) | -$15.68 M(-6.1%) |
| Mar 2023 | - | -$4.76 M(+81.5%) | -$16.70 M(+8.9%) |
| Dec 2022 | -$15.34 M(-21.6%) | -$2.63 M(-41.6%) | -$15.34 M(-9.7%) |
| Sept 2022 | - | -$4.50 M(-6.6%) | -$16.99 M(-9.6%) |
| June 2022 | - | -$4.82 M(+41.9%) | -$18.79 M(-2.1%) |
| Mar 2022 | - | -$3.40 M(-20.5%) | -$19.20 M(-1.9%) |
| Dec 2021 | -$19.57 M(+19.5%) | -$4.27 M(-32.2%) | -$19.57 M(+1.1%) |
| Sept 2021 | - | -$6.30 M(+20.5%) | -$19.35 M(+8.1%) |
| June 2021 | - | -$5.23 M(+38.7%) | -$17.91 M(+0.2%) |
| Mar 2021 | - | -$3.77 M(-7.0%) | -$17.86 M(+9.1%) |
| Dec 2020 | -$16.38 M(-13.7%) | -$4.05 M(-16.5%) | -$16.38 M(+9.3%) |
| Sept 2020 | - | -$4.86 M(-6.3%) | -$14.98 M(+17.3%) |
| June 2020 | - | -$5.19 M(+126.8%) | -$12.77 M(+30.6%) |
| Mar 2020 | - | -$2.29 M(-13.8%) | -$9.78 M(-48.5%) |
| Dec 2019 | -$18.98 M(+15.4%) | -$2.65 M(+0.2%) | -$18.98 M(-23.1%) |
| Sept 2019 | - | -$2.65 M(+20.6%) | -$24.69 M(+3.5%) |
| June 2019 | - | -$2.20 M(-80.9%) | -$23.87 M(-7.4%) |
| Mar 2019 | - | -$11.48 M(+37.2%) | -$25.79 M(+56.9%) |
| Dec 2018 | -$16.44 M | -$8.37 M(+358.8%) | -$16.44 M(+55.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$1.82 M(-55.7%) | -$10.61 M(-2.2%) |
| June 2018 | - | -$4.12 M(+92.9%) | -$10.85 M(+30.7%) |
| Mar 2018 | - | -$2.13 M(-15.9%) | -$8.30 M(+3.9%) |
| Dec 2017 | -$7.99 M(+40.7%) | -$2.54 M(+23.0%) | -$7.99 M(-1.7%) |
| Sept 2017 | - | -$2.06 M(+31.6%) | -$8.13 M(+14.6%) |
| June 2017 | - | -$1.57 M(-14.1%) | -$7.09 M(+7.7%) |
| Mar 2017 | - | -$1.82 M(-31.8%) | -$6.59 M(+37.9%) |
| Dec 2016 | -$5.68 M(>+9900.0%) | -$2.68 M(+160.5%) | -$4.78 M(+124.7%) |
| Sept 2016 | - | -$1.03 M(-3.0%) | -$2.13 M(+92.7%) |
| June 2016 | - | -$1.06 M(+6688.5%) | -$1.10 M(+1891.5%) |
| Feb 2016 | - | -$15.60 K(-34.7%) | -$55.40 K(0.0%) |
| Feb 2016 | -$54.50 K(-96.4%) | - | - |
| Dec 2015 | -$1.52 M(+3481.8%) | - | - |
| Nov 2015 | - | -$23.90 K(+397.9%) | -$55.40 K(+37.5%) |
| Aug 2015 | - | -$4800.00(-56.8%) | -$40.30 K(-13.5%) |
| May 2015 | - | -$11.10 K(-28.8%) | -$46.60 K(+7.4%) |
| Feb 2015 | - | -$15.60 K(+77.3%) | -$43.40 K(+43.7%) |
| Feb 2015 | -$42.40 K(-45.3%) | - | - |
| Nov 2014 | - | -$8800.00(-20.7%) | -$30.20 K(-60.1%) |
| Aug 2014 | - | -$11.10 K(+40.5%) | -$75.60 K(+5.9%) |
| May 2014 | - | -$7900.00(+229.2%) | -$71.40 K(-8.5%) |
| Feb 2014 | -$77.50 K | -$2400.00(-95.6%) | -$78.00 K(+3.2%) |
| Nov 2013 | - | -$54.20 K(+685.5%) | -$75.60 K(+253.3%) |
| Aug 2013 | - | -$6900.00(-52.4%) | -$21.40 K(+47.6%) |
| May 2013 | - | -$14.50 K | -$14.50 K |
FAQ
- What is Zomedica annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Zomedica?
- What is Zomedica annual EBITDA year-on-year change?
- What is Zomedica quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Zomedica?
- What is Zomedica quarterly EBITDA year-on-year change?
- What is Zomedica TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Zomedica?
- What is Zomedica TTM EBITDA year-on-year change?
What is Zomedica annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ZOM is -$29.39 M
What is the all time high annual EBITDA for Zomedica?
Zomedica all-time high annual earnings before interest, taxes, depreciation & amortization is -$42.40 K
What is Zomedica annual EBITDA year-on-year change?
Over the past year, ZOM annual earnings before interest, taxes, depreciation & amortization has changed by -$14.05 M (-91.60%)
What is Zomedica quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ZOM is -$4.70 M
What is the all time high quarterly EBITDA for Zomedica?
Zomedica all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$2400.00
What is Zomedica quarterly EBITDA year-on-year change?
Over the past year, ZOM quarterly earnings before interest, taxes, depreciation & amortization has changed by -$3.94 M (-525.30%)
What is Zomedica TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ZOM is -$54.27 M
What is the all time high TTM EBITDA for Zomedica?
Zomedica all-time high TTM earnings before interest, taxes, depreciation & amortization is -$14.50 K
What is Zomedica TTM EBITDA year-on-year change?
Over the past year, ZOM TTM earnings before interest, taxes, depreciation & amortization has changed by -$42.33 M (-354.67%)